Tracking Skin Self-Exams: What a 12-Month Melanoma Study Found
Regular total skin self-examination is widely recommended to detect changes in skin lesions early, particularly for anyone with a history of skin cancer or individuals monitoring high numbers of moles. However, committing to a consistent self-check routine is notoriously difficult. A 12-month longitudinal study published in BMJ Open evaluated why some patients successfully maintain monthly total skin self-examinations while others struggle or stop over time.
12 Months of Time-Stamped App Tracking in the ASICA Trial
Carried out as an observational study nested within the intervention arm of the Achieving Self-Directed Integrated Cancer Aftercare (ASICA) trial (ClinicalTrials.gov identifier NCT03328247), the project tracked participants over a full 12 months. Rather than relying entirely on patient recall at the end of the year, adherence was verified using time-stamped total skin self-examination data recorded directly through a dedicated tablet application.
The primary outcome was patient adherence to guideline-recommended monthly examinations. By recording exactly when participants completed their self-checks over 12 months, the research team could plot actual behavioral trends rather than idealized estimates.
104 Participants Across Follow-Up Centers
The trial analyzed data from 104 adults receiving secondary care follow-up across two hospital regions in the United Kingdom: Aberdeen and Cambridge. The cohort possessed several distinct baseline characteristics:
- A cohort size of 104 adults, including 48 men alongside female participants.
- A mean participant age of 58.83 years (standard deviation 13.47, with ages beginning at 28).
- A mean Scottish Index of Multiple Deprivation score of 8.03 (standard deviation 1.73, on a scale spanning from 2 to 10).
- All 104 individuals had been treated for stage 0 to IIC primary cutaneous melanoma in the preceding 60 months.
Because every participant had previously undergone treatment for melanoma, they had already received clinical advice regarding the importance of ongoing surveillance for different types of skin cancer.
Three Divergent Trajectories of Patient Adherence
Using latent growth mixture models, researchers found that participants did not follow a single uniform pattern. Instead, patient habits split into three distinct trajectories over the 12 months:
- Adherent trajectory: Patients who consistently maintained the recommended monthly schedule throughout the full year.
- Drop-off trajectory: Individuals who initiated self-checks reliably in the early months but whose adherence progressively declined over time.
- Non-adherent trajectory: Individuals who failed to build or maintain the monthly routine from early in the trial.
Predicting Follow-Through: Psychological and Cognitive Predictors
The published BMJ Open findings showed that demographic factors alone did not explain these pathways. Instead, baseline emotional and cognitive metrics proved decisive:
- Unrealistic inspection intentions: Non-adherent participants were less likely to intend to perform self-exams at the recommended monthly pace, frequently expressing an intention to examine their skin more frequently than clinical guidelines suggest (odds ratio 0.21, 95% confidence interval 0.06 to 0.81, p=0.023).
- Depressive symptoms: Higher baseline depression scores significantly increased the odds of belonging to the non-adherent group (odds ratio 1.31, 95% confidence interval 1.06 to 1.61, p=0.011).
- Weak action planning: Participants in the drop-off trajectory had less structured action plans defining when, where, and how they would carry out their checks (odds ratio 0.78, 95% confidence interval 0.63 to 0.96, p=0.016).
- Lower self-efficacy: Confidence in one's personal capability to perform a thorough skin evaluation was markedly lower among those in the drop-off category (odds ratio 0.92, 95% confidence interval 0.86 to 0.99, p=0.028). Learning structured techniques such as the ABCDE mole check is often emphasized clinically to help build this foundational self-efficacy.
Study Limitations and Clinical Realities
While informative, this research represents a single observational study nested inside an intervention trial where all 104 participants had access to a dedicated tablet application. Generalizing these adherence trajectories to everyday settings without digital support may not be valid. Furthermore, the participants were recruited exclusively from two UK regions and had all been treated for early-stage cutaneous melanoma within the past 60 months.
For those researching tanning peptides, skin monitoring is critical. Unregulated compounds like melanotan I and melanotan II bought online are unapproved drugs that carry unpredictable health risks. Self-checking is a valuable personal habit, but it never replaces scheduled examinations by a qualified doctor or dermatologist.
Sources
Published October 28, 2026. Sources are linked in the text. See our Medical Disclaimer.